Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by CannaRocketson Jan 03, 2018 12:08am
205 Views
Post# 27267867

GOLDMAN SACHS - IMH an acquisition target?

GOLDMAN SACHS - IMH an acquisition target?

IMH considered an acquisition target by Goldman.

Fully funded 15,000 KG to be completed by July 2018 in Alberta (only other licensed producer in this region that is advanced is AURORA, and we all know how aurora loves to get their hands in everything like CMED).

I think they could get acquired at $6 just based on quick napkin math. (P/E of 20 on profits of 30 mil -> $6)

The sales license de-risking can definitely make this possible.

https://technical420.com/cannabis-article/3-cannabis-themes-know-goldman-sachs-upgrade-canadian-ma-activity

Disclosure : I hold IMH shares!


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities